The PI3K-protein kinase B (AKT)-mammalian target of rapamycin (mTOR) cascade is one of the major downstream signaling pathways in human cells (Fruman et al., 2017), and its deregulation has been implicated in breast cancer development and progression (Lee et al., 2015). This evidence concerns the gene PIK3CA and breast carcinoma.